Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Svenja Fischmann

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Beilstein Journal of Organic Chemistry|March 17, 2012
Binding of group 15 and group 16 oxides by a concave host containing an isophthalamide unitJens Eckelmann, Vittorio Saggiomo, Svenja Fischmann, et al.
Drug Testing and Analysis|November 8, 2022
EMCDDA framework and practical guidance for naming synthetic cannabinoidsBenedikt Pulver, Svenja Fischmann, Ana Gallegos, et al.
Drug Testing and Analysis|February 23, 2024
EMCDDA framework and practical guidance for naming cathinonesBenedikt Pulver, Svenja Fischmann, Ana Gallegos, et al.
Archives of Toxicology|July 5, 2022
Going deeper into the toxicokinetics of synthetic cannabinoids: in vitro contribution of human carboxylesterasesLea Wagmann, Rebecca G Stiller, Svenja Fischmann, et al.
Metabolites|September 24, 2020
Comparison of Three Untargeted Data Processing Workflows for Evaluating LC-HRMS Metabolomics DataSelina Hemmer, Sascha K Manier, Svenja Fischmann, et al.
Journal of Analytical Toxicology|February 6, 2020
Toxicokinetic Studies and Analytical Toxicology of the New Synthetic Opioids Cyclopentanoyl-Fentanyl and Tetrahydrofuranoyl-FentanylTanja M Gampfer, Lea Wagmann, Matthias J Richter, et al.
Drug Testing and Analysis|June 23, 2019
Detection of the recently emerged synthetic cannabinoid 4F-MDMB-BINACA in "legal high" products and human urine specimensBelal Haschimi, Lukas Mogler, Sebastian Halter, et al.
Frontiers in Chemistry|August 9, 2020
How to Study the Metabolism of New Psychoactive Substances for the Purpose of Toxicological Screenings-A Follow-Up Study Comparing Pooled Human Liver S9, HepaRG Cells, and Zebrafish LarvaeLea Wagmann, Fabian Frankenfeld, Yu Mi Park, et al.
Drug Testing and Analysis|September 3, 2019
Detection and phase I metabolism of the 7-azaindole-derived synthetic cannabinoid 5F-AB-P7AICA including a preliminary pharmacokinetic evaluationArianna Giorgetti, Lukas Mogler, Belal Haschimi, et al.
Biomolecules|November 27, 2024
Synthesis, Analytical Characterization, and Human CB<sub>1</sub> Receptor Binding Studies of the Chloroindole Analogues of the Synthetic Cannabinoid MDMB-CHMICASascha Münster-Müller, Steven Hansen, Tobias Lucas, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Beilstein Journal of Organic Chemistry|March 17, 2012
Binding of group 15 and group 16 oxides by a concave host containing an isophthalamide unitJens Eckelmann, Vittorio Saggiomo, Svenja Fischmann, et al.
Drug Testing and Analysis|November 8, 2022
EMCDDA framework and practical guidance for naming synthetic cannabinoidsBenedikt Pulver, Svenja Fischmann, Ana Gallegos, et al.
Drug Testing and Analysis|February 23, 2024
EMCDDA framework and practical guidance for naming cathinonesBenedikt Pulver, Svenja Fischmann, Ana Gallegos, et al.
Archives of Toxicology|July 5, 2022
Going deeper into the toxicokinetics of synthetic cannabinoids: in vitro contribution of human carboxylesterasesLea Wagmann, Rebecca G Stiller, Svenja Fischmann, et al.
Metabolites|September 24, 2020
Comparison of Three Untargeted Data Processing Workflows for Evaluating LC-HRMS Metabolomics DataSelina Hemmer, Sascha K Manier, Svenja Fischmann, et al.
Journal of Analytical Toxicology|February 6, 2020
Toxicokinetic Studies and Analytical Toxicology of the New Synthetic Opioids Cyclopentanoyl-Fentanyl and Tetrahydrofuranoyl-FentanylTanja M Gampfer, Lea Wagmann, Matthias J Richter, et al.
Drug Testing and Analysis|June 23, 2019
Detection of the recently emerged synthetic cannabinoid 4F-MDMB-BINACA in "legal high" products and human urine specimensBelal Haschimi, Lukas Mogler, Sebastian Halter, et al.
Frontiers in Chemistry|August 9, 2020
How to Study the Metabolism of New Psychoactive Substances for the Purpose of Toxicological Screenings-A Follow-Up Study Comparing Pooled Human Liver S9, HepaRG Cells, and Zebrafish LarvaeLea Wagmann, Fabian Frankenfeld, Yu Mi Park, et al.
Drug Testing and Analysis|September 3, 2019
Detection and phase I metabolism of the 7-azaindole-derived synthetic cannabinoid 5F-AB-P7AICA including a preliminary pharmacokinetic evaluationArianna Giorgetti, Lukas Mogler, Belal Haschimi, et al.
Biomolecules|November 27, 2024
Synthesis, Analytical Characterization, and Human CB<sub>1</sub> Receptor Binding Studies of the Chloroindole Analogues of the Synthetic Cannabinoid MDMB-CHMICASascha Münster-Müller, Steven Hansen, Tobias Lucas, et al.
Pageof 2